- $304.55m
- $319.29m
- $186.80m
- 55
- 34
- 67
- 51
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 93.8 | 114 | 160 | 188 | 187 |
Cost of Revenue | |||||
Gross Profit | 60.4 | 73.1 | 96 | 113 | 117 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 160 | 173 | 208 | 222 | 217 |
Operating Profit | -66.2 | -58.3 | -48.9 | -34.1 | -30.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -71 | -59.6 | -54.1 | -42.3 | -37.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -71.2 | -59.9 | -54.4 | -42.8 | -37.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -71.2 | -59.9 | -54.4 | -42.8 | -37.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -71.2 | -59.9 | -54.4 | -42.8 | -37.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.509 | -0.365 | -0.316 | -0.241 | -0.195 |